Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-28

Clinical Trial Update: Effect of Menopause Relief EP-40 in Women With Menopausal Symptoms [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Menopause Relief EP-40 in menopausal symptoms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Menopause Relief EP-40

Snippet

Sponsor: EuroPharma, Inc. | Conditions: Menopause | Phase 2 | Status: COMPLETED